# Wake Forest Atrium HeartShare Clinical Center

> **NIH NIH U01** · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2024 · $273,177

## Abstract

Project Summary
Heart failure (HF) with preserved ejection fraction (HFpEF) is most common form of HF in the US and is
associated with high morbidity and mortality. HFpEF disproportionately affects women and non-Hispanic Black
persons. HFpEF is now understood as a heterogeneous syndrome intertwined with aging and multiple
comorbidities, and likely has multiple phenotypes. The pathophysiology remains incompletely understood and
few evidence-based treatments exist. This is the premise for HeartShare, a pivotal NHLBI initiative, whose
ultimate goals are to discover novel biological signals that will lead to actionable targets to inform future HFpEF
interventions.10 HeartShare is developing a Registry of 10,000 HF patients and matched comparators, and a
comprehensive 1000 participant Deep Phenotyping cohort. The Deep Phenotyping arm has to date recruited
262 participants from 7 sites. Of these, 80%, are White, and only 11% are African American, considerably
below the expected goal. There has developed a broad consensus among HeartShare stakeholders that
additional effort and support are needed to develop and implement strategies to help achieve diversity goals,
and specifically for a ‘Diversity Champion’ approach. Without the urgent, coordinated intervention in this
proposal to enhance inclusivity, participant diversity is likely to continue to be suboptimal, jeopardizing
HeartShare’s validity and generalizability. The Wake Forest-Atrium HeartShare Clinical Site has a diverse
investigator team, has consistently exceeded diversity enrollment targets in many clinical studies, and to date
leads overall Heart Share enrollment and has the highest percentage of female participants and the second
highest percentage of Black participants among the 7 sites. The overall goal of this proposal is to enhance
enrollment of under-represented groups across HeartShare sites by carrying out the following Aims: 1)
Completing a comprehensive assessment of resources and strategies for enrolling URM participants at each of
the clinical sites across HeartShare, as well as outcomes to date; 2) Utilizing the results of the comprehensive
assessment to develop optimal practices for enrollment of URM participants in HeartShare, test and refine
them at Wake Forest’s site, and then disseminate and help implement them across all HeartShare sites; 3)
Continuously monitor progress and dynamically adjust strategies as needed to help ensure optimal participant
diversity and inclusion across HeartShare. Our proposal is supported by: 1) An unexpected, compelling need
in a pivotal, ongoing NHLBI study; 2) Preliminary data indicating lack of a cohesive, robust, organized
approach to diversity and inclusion; 3) a diverse, multi-disciplinary leadership team consisting of a promising
minority female early career investigator combined with highly experienced senior investigators and staff, who
together have developed a strong track record for diverse participant enrollment in HeartShare and m...

## Key facts

- **NIH application ID:** 11144871
- **Project number:** 3U01HL160272-04S1
- **Recipient organization:** WAKE FOREST UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** DALANE W KITZMAN
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $273,177
- **Award type:** 3
- **Project period:** 2021-09-10 → 2026-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11144871

## Citation

> US National Institutes of Health, RePORTER application 11144871, Wake Forest Atrium HeartShare Clinical Center (3U01HL160272-04S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11144871. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
